Amgen’s Imdelltra (Tarlatamab-dlle) Receives the US FDA’s Approval to Treat Extensive-Stage Small Cell Lung Cancer
Shots: The US FDA has granted accelerated approval to Amgen’s Imdelltra (DLL...
BMS Reports the US FDA’s Accelerated Approval of Breyanzi for Treating Follicular Lymphoma (FL)
Shots: The US FDA’s accelerated approval of Breyanzi for r/r FL adults treat...
The US FDA Rejects Dynavax’ Four-Dose Heplisav-B Regimen for Adults on Hemodialysis
Shots: The US FDA issued a Complete Response Letter (CRL) for the four-dose Heplis...
Roche Receives the US FDA’s Approval for HPV Self-Collection Solutions for Cervical Cancer
Shots: Roche has received the US FDA’s approval for its human papillomavirus...
Merus’ Petosemtamab Receives the US FDA’s Breakthrough Therapy Designation for Head and Neck Squamous Cell Carcinoma
Shots: The BTD was granted to petosemtamab for treating recurrent/metastatic HNSCC...
Zai Lab’s Augtyro Receives the NMPA’s Approval to Treat Non-Small-Cell Lung Cancer (NSCLC)
Shots: The NMPA has approved Augtyro for treating locally advanced or metastatic R...
